Pancreatic Cancer Research

ResearcherTianjin UniversityNo recent work listed

Chunwan Lu

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0002-3823-9434; OpenAlex author ID A5036361334.

Their work

Papers
5 (first author 5, last author 0)
Trials
0
Grants
0
Collaborators
5
Papers, trials and grants by year

2017: 3 papers · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 5

  1. WDR5-H3K4me3 epigenetic axis regulates OPN expression to compensate PD-L1 function to promote pancreatic cancer immune escape. First author DOI 10.1136/jitc-2021-002624↗
  2. Contrasting roles of H3K4me3 and H3K9me3 in regulation of apoptosis and gemcitabine resistance in human pancreatic cancer cells. First author DOI 10.1186/s12885-018-4061-y↗
  3. JAK-STAT-mediated chronic inflammation impairs cytotoxic T lymphocyte activation to decrease anti-PD-1 immunotherapy efficacy in pancreatic cancer. First author DOI 10.1080/2162402x.2017.1291106↗
  4. The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion. First author DOI 10.1093/jnci/djw283↗
  5. Epigenetic regulation of PD-L1 expression and pancreatic cancer response to checkpoint immunotherapy. First author DOI 10.21037/tcr.2017.05.32↗

Closest collaborators

The 5 strongest of 5 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Kebin Liu · 5 shared papers, 2017–2021
  2. Maria Eugenia Sabbatini · 2 shared papers, 2017–2018
  3. Nicholas H. Oberlies · 2 shared papers, 2017–2018
  4. Aaron Henry Colby · 1 shared paper, 2018
  5. Mark W. Grinstaff · 1 shared paper, 2018

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.